13-101057246-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_052867.4(NALCN):​c.5023+693G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 152,226 control chromosomes in the GnomAD database, including 14,441 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 14431 hom., cov: 32)
Exomes 𝑓: 0.29 ( 10 hom. )

Consequence

NALCN
NM_052867.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.26

Publications

2 publications found
Variant links:
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN-AS1 (HGNC:42743): (NALCN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.572 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NALCNNM_052867.4 linkc.5023+693G>C intron_variant Intron 43 of 43 ENST00000251127.11 NP_443099.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NALCNENST00000251127.11 linkc.5023+693G>C intron_variant Intron 43 of 43 1 NM_052867.4 ENSP00000251127.6

Frequencies

GnomAD3 genomes
AF:
0.428
AC:
65081
AN:
151914
Hom.:
14409
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.497
Gnomad AMI
AF:
0.418
Gnomad AMR
AF:
0.324
Gnomad ASJ
AF:
0.437
Gnomad EAS
AF:
0.588
Gnomad SAS
AF:
0.512
Gnomad FIN
AF:
0.546
Gnomad MID
AF:
0.405
Gnomad NFE
AF:
0.373
Gnomad OTH
AF:
0.432
GnomAD4 exome
AF:
0.289
AC:
56
AN:
194
Hom.:
10
Cov.:
0
AF XY:
0.304
AC XY:
28
AN XY:
92
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AF:
0.00
AC:
0
AN:
10
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.500
AC:
1
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.299
AC:
52
AN:
174
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.429
AC:
65150
AN:
152032
Hom.:
14431
Cov.:
32
AF XY:
0.438
AC XY:
32581
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.498
AC:
20632
AN:
41464
American (AMR)
AF:
0.324
AC:
4945
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.437
AC:
1516
AN:
3472
East Asian (EAS)
AF:
0.589
AC:
3039
AN:
5158
South Asian (SAS)
AF:
0.513
AC:
2474
AN:
4824
European-Finnish (FIN)
AF:
0.546
AC:
5767
AN:
10564
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.373
AC:
25364
AN:
67974
Other (OTH)
AF:
0.435
AC:
916
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1877
3753
5630
7506
9383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.255
Hom.:
608
Bravo
AF:
0.413
Asia WGS
AF:
0.523
AC:
1823
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.082
DANN
Benign
0.52
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs638732; hg19: chr13-101709598; API